• LAST PRICE
    0.0547
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0450/ 100
  • Ask / Lots
    0.0547/ 100
  • Open / Previous Close
    0.0000 / 0.0547
  • Day Range
    ---
  • 52 Week Range
    Low 0.0280
    High 0.1098
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIVRO
Invitro International
1.2M
156.3x
-17.03%
United StatesBSPK
Bespoke Extracts Inc
1.1M
-0.8x
---
United StatesULUR
Altrazeal Life Sciences Inc
20.0
0.0x
---
United StatesOPGX
Optigenex Inc
120.0
0.0x
---
United StatesMCOA
Marijuana Company Of America Inc
2.2M
0.0x
---
United StatesNLBS
Nutralife Biosciences Inc
17.7K
0.0x
---
As of 2024-04-26

Company Information

InVitro International, Inc. is a customer and technology-driven provider of non-animal testing methods. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. The Company produces and sells in vitro assay kits to detect, rank and predict the potential level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). It sells its products direct to customers, independent partner laboratories, and agents in the United States, Europe, Latin America and Asia. It also sells vitro products, which include Ocular Irritection, which is used to evaluate the potential for ocular irritation; Irritection Dermal, which is used to evaluate the potential for dermal irritation and Corrositex, which is used to determine corrosivity level classifications. It also conducts laboratory testing for those customers who prefer not to conduct their own tests.

Contact Information

Headquarters
330 E Orangethorpe Ave Ste DPLACENTIA, CA, United States 92870
Phone
949-851-8356
Fax
949-851-4985

Executives

Chairman of the Board
Irwin Gruverman
President, Chief Executive Officer, Director
W. Richard Ulmer
Senior Vice President, Director
Dennis Chenoweth
Secretary, Director
William Curtis
Director
David Reed

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.2M
Revenue (TTM)
$716.9K
Shares Outstanding
22.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.78
EPS
$0.00
Book Value
$0.03
P/E Ratio
156.3x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
---
Operating Margin
-1.84%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.